Cohort has a number of analysts actively publishing research on the company.
Last updated: 10 December 2025
Consensus
| Year ended 30 April 2026 |
Year ended 30 April 2027 |
Year ended 30 April 2028 |
|
|---|---|---|---|
| Analysts |
4 |
4 |
2 |
| Revenue (£m) |
291.6 |
314.8 |
340.0 |
| Adjusted operating profit (£m) |
34.8 |
41.0 |
47.2 |
| Adjusted EPS (pence) |
59.5 |
66.4 |
74.7 |
| Adjusted dividend per share (pence) |
17.9 |
19.8 |
22.1 |
| Net funds/(debt) (£m) |
13.0 |
26.1 |
47.9 |
Coverage
Andy Edmond
See recent research reports
Email: andy@equitydevelopment.co.uk
Tel: +44 20 7065 2690
Ben Bourne
Email: ben.bourne@investec.co.uk
Tel: +44 (0) 207 597 5889
Ben Pfannes-Varrow
Email: ben.pfannesvarrow@rbccm.com
Ph: +44 204 557 7415
Robin Byde
Email: robin.byde@zeuscapital.co.uk
Tel: +44 203 829 5000
Related content
Why invest?
We are committed to delivering value to shareholders and ensuring they benefit from our success in the form of dividend growth.
Why invest?
Results, reports & presentations
View the latest results, reports, presentations and videos.
Results, reports & presentations
Shareholder information
Cohort securities are traded only on AIM and are not subject to any restrictions of transfer.
Shareholder information